Cargando…
Convalescent plasma treatment for patients of 80 years and older with COVID-19 pneumonia
BACKGROUND: Older patients, frequently with multiple comorbidities, have a high mortality from COVID-19 infection. Convalescent plasma (CP) is a therapeutic option for these patients. Our objective is to retrospectively evaluate the efficacy and adverse events of CP treatment in this population grou...
Autores principales: | Romon, Iñigo, Dominguez-Garcia, Juan J., Arroyo, Jose L., Suberviola, Borja, Cabezón, Itxasne, Abascal, Beatriz, Baldeón, Cristina, Cuesta, Amalia, Portilla, Raquel, Casuso, Elena, Ocio, Enrique, Briz, Montserrat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521266/ https://www.ncbi.nlm.nih.gov/pubmed/34663227 http://dx.doi.org/10.1186/s12877-021-02447-9 |
Ejemplares similares
-
Map of ubiquitin-like post-translational modifications in chronic lymphocytic leukemia. Role of p53 lysine 120 NEDDylation
por: Bravo-Navas, Sara, et al.
Publicado: (2021) -
Management of hyperinflammation in COVID-19 patients
por: Suberviola, Borja, et al.
Publicado: (2022) -
Methylene blue-treated plasma, versus quarantine fresh frozen plasma, for acute thrombotic thrombocytopenic purpura treatment: Comparison between centres and critical review on longitudinal data
por: Arroyo, José Luis, et al.
Publicado: (2020) -
Validation of the Computerized Cognitive Assessment Test: NNCT
por: Oliva, Itxasne, et al.
Publicado: (2022) -
Convalescents
Publicado: (1907)